ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,302.40
-0.11%
Dow Jones
40,659.76
0.24%
Gold vs US Dollar
2,502.91
-0.15%
Brent Oil
78.765
-0.09%
Bitcoin
58,610.06
0.03%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Plus Therapeutics Inc (PSTV)

  7. Plus Therapeutics Inc (PSTV) News

Plus Therapeutics (PSTV)

Plus Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PSTV
DateTimeSourceHeadlineSymbolCompany
15/08/202421:53Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PSTVPlus Therapeutics Inc
15/08/202421:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSTVPlus Therapeutics Inc
14/08/202421:48Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PSTVPlus Therapeutics Inc
14/08/202421:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PSTVPlus Therapeutics Inc
14/08/202421:16GlobeNewswire Inc.Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:PSTVPlus Therapeutics Inc
14/08/202421:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSTVPlus Therapeutics Inc
13/08/202412:30GlobeNewswire Inc.Plus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases ConferenceNASDAQ:PSTVPlus Therapeutics Inc
12/08/202412:30GlobeNewswire Inc.Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at 2024 SNO/ASCO CNS Metastases ConferenceNASDAQ:PSTVPlus Therapeutics Inc
08/08/202412:30GlobeNewswire Inc.Plus Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 14, 2024NASDAQ:PSTVPlus Therapeutics Inc
25/07/202412:30GlobeNewswire Inc.Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO ConferenceNASDAQ:PSTVPlus Therapeutics Inc
12/07/202421:40Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:PSTVPlus Therapeutics Inc
10/07/202417:12Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PSTVPlus Therapeutics Inc
10/07/202412:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PSTVPlus Therapeutics Inc
02/07/202412:30GlobeNewswire Inc.Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of CancerNASDAQ:PSTVPlus Therapeutics Inc
07/06/202422:02Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PSTVPlus Therapeutics Inc
07/06/202421:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSTVPlus Therapeutics Inc
07/06/202412:30GlobeNewswire Inc.Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRITNASDAQ:PSTVPlus Therapeutics Inc
05/06/202412:26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PSTVPlus Therapeutics Inc
04/06/202422:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSTVPlus Therapeutics Inc
20/05/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSTVPlus Therapeutics Inc
17/05/202422:00GlobeNewswire Inc.Plus Therapeutics Announces New Employment Inducement GrantsNASDAQ:PSTVPlus Therapeutics Inc
15/05/202421:15GlobeNewswire Inc.Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:PSTVPlus Therapeutics Inc
15/05/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSTVPlus Therapeutics Inc
15/05/202421:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PSTVPlus Therapeutics Inc
13/05/202412:30GlobeNewswire Inc.Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024NASDAQ:PSTVPlus Therapeutics Inc
10/05/202412:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
10/05/202412:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
10/05/202412:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
10/05/202412:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
10/05/202412:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PSTV

Your Recent History

BIT
I07190
INTESA SANPAOLO
BIT
SCOF7L
Societe Generale Effekten
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved